BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17090666)

  • 1. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
    Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development.
    Sausville J; Molinolo AA; Cheng X; Frampton J; Takebe N; Gutkind JS; Feldman RA
    Clin Cancer Res; 2008 Jun; 14(12):3948-55. PubMed ID: 18559617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors.
    Siwko SK; Bu W; Gutierrez C; Lewis B; Jechlinger M; Schaffhausen B; Li Y
    Neoplasia; 2008 Jul; 10(7):653-62, 1 p following 662. PubMed ID: 18592025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammary cells with active Wnt signaling resist ErbB2-induced tumorigenesis.
    Bu W; Zhang X; Dai H; Huang S; Li Y
    PLoS One; 2013; 8(11):e78720. PubMed ID: 24265712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the RCAS-TVA system to model human cancer in mice.
    Ahronian LG; Lewis BC
    Cold Spring Harb Protoc; 2014 Nov; 2014(11):1128-35. PubMed ID: 25368315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance.
    Pao W; Klimstra DS; Fisher GH; Varmus HE
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8764-9. PubMed ID: 12857957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors.
    Seidler B; Schmidt A; Mayr U; Nakhai H; Schmid RM; Schneider G; Saur D
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10137-42. PubMed ID: 18621715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
    Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
    Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RCAS-TVA in the mammary gland: an in vivo oncogene screen and a high fidelity model for breast transformation?
    Du Z; Li Y
    Cell Cycle; 2007 Apr; 6(7):823-6. PubMed ID: 17377492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
    Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
    Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.
    Hu C; DiƩvart A; Lupien M; Calvo E; Tremblay G; Jolicoeur P
    Am J Pathol; 2006 Mar; 168(3):973-90. PubMed ID: 16507912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RCAS-TVA system for introduction of oncogenes into selected somatic mammary epithelial cells in vivo.
    Reddy JP; Li Y
    J Mammary Gland Biol Neoplasia; 2009 Dec; 14(4):405-9. PubMed ID: 19936988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
    Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
    Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
    J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.
    Verbeke S; Richard E; Monceau E; Schmidt X; Rousseau B; Velasco V; Bernard D; Bonnefoi H; MacGrogan G; Iggo RD
    Breast Cancer Res; 2014 Dec; 16(6):504. PubMed ID: 25527189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype.
    Holloway KR; Sinha VC; Bu W; Toneff M; Dong J; Peng Y; Li Y
    Int J Biol Sci; 2016; 12(4):381-8. PubMed ID: 27019623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.